EntryPoint Capital »

Foghorn Therapeutics shares owned by EntryPoint Capital

Quarter-by-quarter ownership of Foghorn Therapeutics (FHTX) shares owned by EntryPoint Capital from 13F filings

Historical chart of EntryPoint Capital investment in Foghorn Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Foghorn Therapeutics held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Foghorn Therapeutics by EntryPoint Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $76k 16k 4.88

More positions owned by EntryPoint Capital

Standardaero (SARO)
Howmet Aerospace (HWM)
Benchmark Electronics (BHE)
Capital One Financial (COF)
Hayward Hldgs (HAYW)
Huntington Bancshares Incorporated (HBAN)
Bank of America Corporation (BAC)
RBC Bearings Incorporated (RBC)
Gilead Sciences (GILD)
Avient Corp (AVNT)
Donaldson Company (DCI)
Universal Display Corporation (OLED)
Helios Technologies (HLIO)
HEICO Corporation (HEI)
American Homes 4 Rent Cl A (AMH)

View all positions for EntryPoint Capital

Top funds holding Foghorn Therapeutics

Flagship Ventures Management
BVF
FMR
Deerfield Management Company
BlackRock
Raymond James Financial
Euclidean Capital
Vanguard Capital Management
Geode Capital Management
Siren
State Street Corporation
Ameriprise Financial
Renaissance Technologies
Candriam Luxembourg S.C.A.
Northern Trust

View all funds holding Foghorn Therapeutics